The Role of Dynamic Contrast Enhanced Magnetic Resonance Enterography in Evaluation of Crohn's Disease Activity

Amaç: Dinamik kontrastlı sekansların konvansiyonel manyetik rezonans enterografiye eklenmesinin Crohn hastalığı (CH) aktivitesinin tespitine katkısını değerlendirmek amaçlanmıştır. Gereç ve Yöntem: Crohn hastalığı tanılı ve Crohn hastalığı şüphesi bulunan 28 hastaya yapılmış olan manyetik rezonans enterografi (MRE) incelemeleri ve hasta dosyaları retrospektif olarak değerlendirilmiştir. Kolonoskopileri ve patolojik tanıları mevcut olan hastalardan aktif CH olarak değerlendirilen 17 hasta çalışmaya dahil edildi. MRE’ler üzerinden zaman intensite eğrisi yoluyla semikantitatif parametreler olan maksimum kontrast enhansmanı, maksimum rölatif enhansman, wash-in oranı, tpeak, dinamik enhansman oranı, statik enhansman oranı, enhansman eğrisi, eğri altında kalan (AUC) alan hesaplandı. Bulgular: Aktif hastalıklı 17 hastanın toplam 43 bağırsak segmenti (26 tutulmuş, 17 normal) değerlendirildi. Tüm semikantitatif parametreler içinde sadece AUC tutulmuş ve normal bağırsak segmentleri arasında istatistiksel olarak anlamlı olarak farklı bulunmuştur. Sonuç: Bizim sonuçlarımız tek başına aktif enflamasyonu kolonoskopi ve patolojik doğrulamadan daha güvenilir olarak gösterebilecek semikantitatif bir parametrenin olmadığını göstermiştir.

Dinamik Kontrastlı Manyetik Rezonans Enterografinin Crohn Hastalığı Aktivitesi Tayinindeki Rolü

Objective: This study assessed the benefits of adding dynamic contrast-enhanced images to conventional magnetic resonance enterography (MRE) for detecting Crohn’s disease (CD) activity. Material and Method: The MRE images and files of 28 patients diagnosed with or suspected of having Crohn’s disease were reviewed. Colonoscopy was performed in all subjects. This study included 17 patients with both colonoscopic findings and histological evidence of active CD. All patients underwent dynamic contrast-enhanced MRE. The following semiquantitative parameters were derived from the time-intensity curve: the maximum contrast enhancement, maximum relative enhancement, wash-in rate, time to peak, dynamic and static enhancement ratios, slope of enhancement, and area under the curve (AUC). Results: In total, 43 bowel segments (26 involved, 17 normal) in the 17 patients with active disease were analyzed. Of the semiquantitative parameters, only the AUC differed significantly (p<0.05) between involved and normal bowel segments. Conclusion: No one semiquantitative parameter alone can identify active inflammation more reliably than colonoscopy and pathological confirmation.

___

  • Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277- 84.
  • Rieber A, Wruk D, Potthast S, et al. Diagnostic imaging in Crohn’s disease: comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis 2000; 15: 176-81.
  • Schmidt S, Lepori D, Meuwly JY, et al. Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of “sign-by-sign” correlation. Eur Radiol 2003; 13: 1303-11.
  • Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigrap hy, and CT: meta-analysis of prospectivestudies. Radiology 2008; 247: 64– 79.
  • Florie J, Wasser MN, Arts-Cieslik K, Akkerman EM, Siersema PD, Stoker J. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. AJR Am J Roentgenol 2006; 186: 1384-92.
  • Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2006; 238: 517- 30.
  • Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn’s disease. AJR Am J Roentgenol 2001; 177: 1325-32.
  • 15. Shoenut JP, Semelka RC, Magro CM, et al. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 1994; 19: 31-5. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000; 25: 219-28.
  • Low RN, Sebrechts CP, Politoske DA, et al. Crohn disease with endoscopic correlation: single-shot-fast spin-echo and gadolinium- enhanced fat-suppressed spoiled gradient-echo MR imaging. Radiology 2002; 222: 652-60.
  • Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigrap hy, and CT: meta-analysis of prospectivestudies. Radiology 2008; 247: 64- 79.
  • Lee SS, Kim AH, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and smallbowel follow-through as diagnostic techniques. Radiology 2009; 251: 751-61.
  • Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in smallbowel Crohn’s disease. AJR Am J Roentgenol 2009; 193: 113-21.
  • Brahme F, Lindström C. A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn’s disease and in ulcerative colitis. Gut 1970; 11: 928-40.
  • Oto A, Kayhan A, Williams JT, et al. Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging. J Magn Reson Imaging 2011; 33: 615-24.
  • Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology 1976; 70: 439-44. van Hees PA, van Elteren PH, van Lier HJ, van Tongeren JH. An index of inflammatory activity in patients with Crohn’s disease. Gut 1980; 21: 279-86.
  • Pauls S, Kratzer W, Rieber A, et al. Quantifying the inflammatory activity in Crohn’s disease using CE dynamic MRI [in German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2003; 175: 1093-9.
  • Oto A, Fan X, Mustafi D, et al. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn’s disease pilot study. Acad Radiol 2009; 16: 1223-30.
  • Born C, Nagel B, Leinsinger G, Reiser M. MRI with oral filling in patients with chronic inflammatory bowel diseases [in German]. Radiologe 2003; 43: 34-42.
  • Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB. Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol 1993; 17: 73-8.
Fırat Tıp Dergisi-Cover
  • ISSN: 1300-9818
  • Başlangıç: 2015
  • Yayıncı: Fırat Üniversitesi Tıp Fakültesi